Arcus Biosciences RCUS
NYSE RCUS
$26.17 +0.52 (+2.03%)
As of: Sep 30, 2026 · 11:35 AM EDT

Arcus Biosciences (RCUS) EV to CFO (2020 - 2022)

Updated

Arcus Biosciences' EV to CFO was 1.14 in Q4 2022, down 39.8% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) EV to CFO (2020 - 2022) Analysis & Trends

From Q3 2020 onward, Arcus Biosciences has reported EV to CFO for 8 quarters.

  • In earlier years, EV to CFO was 8.66 in FY2020.
  • The Q4 2022 figure marks the lowest quarterly EV to CFO in data going back to Q3 2020.
  • Per Business Quant data, RCUS's EV to CFO in the three quarters before Q4 2022 was 1.89 (Q3 2022), 1.38 (Q2 2022) and 2.25 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Arcus Biosciences 3.18 Bn -157.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.14
Sep 30, 2022 1.89
Jun 30, 2022 1.38
Mar 31, 2022 2.25
Jun 30, 2021 47.83
Mar 31, 2021 15.35
Dec 31, 2020 8.66
Sep 30, 2020 2.18
API Access

Arcus Biosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=RCUS&period=max&api_key=YOUR_API_KEY